In Singapore, lung cancer is the third most common cancer among men and women.

Lung cancer is also the leading cause of cancer death for men and third cause of cancer death for women.

It is a type of cancer that begins in the lungs and develops because of the uncontrolled growth of abnormal cells.

Growth of these abnormal cells can interfere with normal lung function. The abnormal cells can pass from the original part of the lung to other parts of the body, such as the opposite lung, our lymph nodes, bones, liver and more.

Over a five-year period, from 2016-2020, close to 8,620 cases of lung cancer were diagnosed in Singapore.

Lung cancer is more commonly diagnosed in individuals above 40 years old, however the disease can occur in younger individuals.

In this Q&A forum, Clinical Assistant Professor Gillianne Lai, Consultant with the Division of Medical Oncology at National Cancer Centre Singapore (NCCS), a member of the SingHealth group, answers your questions on lung cancer.

This Q&A forum is open from 1 Feb to 26 Feb 2023.

 

Click here to post your questions

 

About Clin Asst Prof Gilliane Lai

Clinical Assistant Professor Gillianne Lai is a Consultant in the Division of Medical Oncology at the National Cancer Centre Singapore (NCCS), sub-specialising in thoracic, head and neck, and genitourinary cancers.

She received her undergraduate training from the Yong Loo Lin School of Medicine, National University of Singapore and is a member of the Royal College of Physicians of the United Kingdom.

Dr Lai currently leads the Lung Cancer Consortium Singapore (LCCS), and is the Principal Investigator of the National Lung Cancer Research (NLCR) study which aims to improve lung cancer care.

Ref: I23